Retrospective study whether influence to the effect of Osimertinib by the kind of previous EGFR-TKI

Retrospective study whether influence to the effect of Osimertinib by the kind of previous EGFR-TKI - Retrospective study whether influence to the effect of Osimertinib by the kind of previous EGFR-TKI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041480

Enrollment

Registered

2020-08-21

Start date

2020-08-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: NSCLC Possible to tissue analysis of the EGFR mutation after EGFR-TKI

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Evaluate whether influence to the effect of Osimertinib by the kind of previous EGFR-TKI	—

Countries

Japan

Contacts

Public ContactMotohiro Tamiya

Osaka International Cancer Institute Thoracic Oncology

moto19781205@yahoo.co.jp06-6945-1181

Outcome results